Screener
Enliven Therapeutics ELVN Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $2.34B.
The source filing: Enliven Therapeutics’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211982
FAQ
- What is Enliven Therapeutics's market capitalization?
- Enliven Therapeutics (ELVN) reported market capitalization of $2.34B in Q1 2026.
- How has Enliven Therapeutics's market capitalization changed year-over-year?
- Enliven Therapeutics's market capitalization increased by 143.1% year-over-year, from $964.41M to $2.34B.
- What is the long-term trend for Enliven Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), Enliven Therapeutics's market capitalization has grown at a 18.7% compound annual growth rate (CAGR), from $387.58M to $913.95M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Enliven Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude